Riverhead Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Riverhead Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$365K	Hold	4,887	–	–	0.01%	860
2019 Q2	$394K	Hold	4,887	–	–	0.01%	831
2019 Q1	$327K	Hold	4,887	–	–	0.01%	896
2018 Q4	$364K	Hold	4,887	–	–	0.02%	792
2018 Q3	$450K	Buy	4,887 +1,100	+29%	+$105K	0.02%	795
2018 Q2	$372K	Hold	3,787	–	–	0.01%	800
2018 Q1	$422K	Hold	3,787	–	–	0.02%	725
2017 Q4	$390K	Buy	3,787 +600	+19%	+$59.8K	0.02%	764
2017 Q3	$300K	Buy	3,187 +390	+14%	+$30.8K	0.01%	804
2017 Q2	$218K	Buy	2,797 +1,297	+86%	+$97.4K	0.01%	881
2017 Q1	$120K	Sell	1,500 -100	-6%	-$7.95K	0.01%	926
2016 Q4	$126K	Hold	1,600	–	–	0.01%	886
2016 Q3	$125K	Sell	1,600 -192,253	-99%	-$13.9M	0.01%	820
2016 Q2	$12.3M	Buy	193,853 +186,901	+2,688%	+$12.9M	0.4%	60
2016 Q1	$496K	Sell	6,952 -948	-12%	-$59.5K	0.01%	885
2015 Q4	$491K	Buy	7,900 +5,400	+216%	+$329K	0.01%	906
2015 Q3	$142K	Buy	+2,500	New	+$132K	﹤0.01%	884

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Riverhead Capital Management's CMD Position: Q3 2019 in Review

Riverhead Capital Management held its Cantel Medical Corporation (CMD) position steady in Q3 2019 at 4,887 shares worth $365K. The position accounts for 0.01% of the portfolio, ranked #860.

Riverhead Capital Management first reported a position in CMD in Q3 2015 and has held it in 17 quarters since. The position peaked at $12.3M in Q2 2016. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

Riverhead Capital Management held 4,887 shares of Cantel Medical Corporation worth $365K as of Q3 2019.
Riverhead Capital Management left its Cantel Medical Corporation share count unchanged in Q3 2019.
Cantel Medical Corporation made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #860 holding.
Riverhead Capital Management first reported a position in Cantel Medical Corporation in Q3 2015 and has held it in 17 quarters since.
Riverhead Capital Management's Cantel Medical Corporation position peaked at $12.3M in Q2 2016.
244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.